DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Kanda T, Jackson MJ, Smith LA. et al.
Combined use of the adenosine A2A antagonist KW–6002 with L–DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP–treated monkeys.
Exp Neurol 2000;
162: 321-327
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.